<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Acalculous cholecystitis: Clinical manifestations, diagnosis, and management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Acalculous cholecystitis: Clinical manifestations, diagnosis, and management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Acalculous cholecystitis: Clinical manifestations, diagnosis, and management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nezam H Afdhal, MD, FRCPI</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stanley W Ashley, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keith D Lindor, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acalculous cholecystitis is an acute necroinflammatory disease of the gallbladder with a multifactorial pathogenesis. It accounts for approximately 10 percent of all cases of acute cholecystitis and is associated with high morbidity and mortality rates.</p><p>This topic will review the pathophysiology, diagnosis, and management of acalculous cholecystitis. Clinical issues related to acute calculous cholecystitis and chronic cholecystitis are discussed separately. (See  <a class="medical medical_review" href="/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3684.html" rel="external">"Treatment of acute calculous cholecystitis"</a>.) </p><p class="headingAnchor" id="H65323845"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Acalculous cholecystitis results from gallbladder stasis and ischemia, which then cause a local inflammatory response in the gallbladder wall. The majority of patients with acalculous cholecystitis have multiple risk factors  (<a class="graphic graphic_table graphicRef82539" href="/d/graphic/82539.html" rel="external">table 1</a>) [<a href="#rid1">1-7</a>]. In some cases, specific primary infections predispose to acalculous cholecystitis  (<a class="graphic graphic_table graphicRef56077" href="/d/graphic/56077.html" rel="external">table 2</a>). As an example, acalculous cholecystitis occurring in patients with acquired immunodeficiency syndrome (AIDS) and other immunosuppressed patients may be due to opportunistic infections such as microsporidia, <em>Cryptosporidium</em>, or cytomegalovirus [<a href="#rid8">8</a>]. More often, however, these infections cause a cholangiopathy without cholecystitis. (See  <a class="medical medical_review" href="/d/html/667.html" rel="external">"AIDS cholangiopathy"</a>.)</p><p>Pathologically in patients with acalculous cholecystitis, endothelial injury, gallbladder ischemia, and stasis, lead to concentration of bile salts, gallbladder distension, and eventually necrosis of the gallbladder tissue. Once acalculous cholecystitis is established, secondary infection with enteric pathogens, including <em>Escherichia coli</em>, <em>Enterococcus faecalis</em>, <em>Klebsiella </em>spp, <em>Pseudomonas </em>spp, <em>Proteus</em> spp, and <em>Bacteroides fragilis</em> and related strains,<em> </em>is common [<a href="#rid9">9</a>]. Perforation occurs in severe cases [<a href="#rid10">10,11</a>]. (See <a class="local">'Complications'</a> below.)</p><p class="headingAnchor" id="H65324085"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Acalculous cholecystitis is typically seen in patients who are hospitalized and critically ill, though it may also be seen in the outpatient setting in patients with risk factors for acalculous cholecystitis  (<a class="graphic graphic_table graphicRef82539" href="/d/graphic/82539.html" rel="external">table 1</a>). Acalculous cholecystitis has been reported in 0.7 to 0.9 percent of patients following open abdominal aortic reconstruction, in 0.5 percent of patients following cardiac surgery, and in as many as 4 percent of patients who have undergone bone marrow transplantation [<a href="#rid4">4,12-15</a>]. There is a male preponderance among patients with acute acalculous cholecystitis ranging from 40 to 80 percent [<a href="#rid12">12,16</a>]. </p><p>The incidence of acalculous cholecystitis in outpatients is not well defined. In one of the largest single center reports, 36 of 47 patients (77 percent) identified over a seven-year period developed symptoms at home without evidence of acute illness or trauma [<a href="#rid17">17</a>]. Significant vascular disease was observed in 72 percent of these patients. Although this suggests that the relative incidence in outpatients may be much higher than is generally recognized, some of these patients may have been misclassified as having acalculous cholecystitis since it is possible that gallstones or microcrystals had not been appreciated.</p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H3880335637"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>The clinical presentation of acalculous cholecystitis varies based on the severity of illness and underlying predisposing conditions  (<a class="graphic graphic_table graphicRef82539" href="/d/graphic/82539.html" rel="external">table 1</a>). In critically ill patients, the appearance of unexplained fever may be the only sign of acalculous cholecystitis. The physical examination may reveal a palpable right upper quadrant mass and rarely jaundice [<a href="#rid17">17</a>]. Jaundice typically results from sepsis-related cholestasis or partial biliary obstruction induced by inflammation extending into the common bile duct. However, it may also occur as a result of extrinsic compression of the common bile duct by a phlegmon (Mirizzi-type syndrome). Because the presentation may be insidious, patients may have sepsis, shock, and peritonitis at presentation due to complications including gallbladder necrosis, gangrene, or perforation. Patients with emphysematous cholecystitis may have crepitus of the right upper quadrant. (See <a class="local">'Complications'</a> below and  <a class="medical medical_review" href="/d/html/656.html" rel="external">"Mirizzi syndrome"</a>.)</p><p>In outpatients or in the critically ill who are able to provide a more detailed history, the presentation may be similar to that seen in calculous cholecystitis, with fever, severe right upper quadrant pain with tenderness to palpation, and a positive Murphy's sign (pain elicited during inspiration while palpating the right upper quadrant) [<a href="#rid18">18,19</a>]. (See  <a class="medical medical_review" href="/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis", section on 'Clinical manifestations'</a>.)</p><p>Although a smoldering presentation characterized by recurrent biliary symptoms for months or years had previously been attributed to "chronic acalculous cholecystitis", the evaluation for concurrent gallstones or microcrystals has been limited [<a href="#rid20">20,21</a>]. These patients may in fact have had gallstone-related disease or functional gallbladder disorder. (See  <a class="medical medical_review" href="/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/654.html" rel="external">"Overview of gallstone disease in adults"</a> and  <a class="medical medical_review" href="/d/html/16725.html" rel="external">"Functional gallbladder disorder in adults"</a>.)</p><p class="headingAnchor" id="H231456978"><span class="h2">Laboratory tests</span><span class="headingEndMark"> — </span>Laboratory tests in patients with acalculous cholecystitis are nonspecific. Leukocytosis is present in 70 to 85 percent of patients [<a href="#rid22">22</a>]. Abnormal liver tests include conjugated hyperbilirubinemia and a mild increase in serum alkaline phosphatase and serum aminotransferases [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests"</a>.)</p><p class="headingAnchor" id="H1810275760"><span class="h2">Complications</span><span class="headingEndMark"> — </span>Similar to patients with acute calculous cholecystitis, complication of acalculous cholecystitis include emphysematous cholecystitis, gangrene, and perforation  (<a class="graphic graphic_diagnosticimage graphicRef56763" href="/d/graphic/56763.html" rel="external">image 1</a>) [<a href="#rid1">1,19</a>]. Gallbladder gangrene develops in approximately 50 percent of patients with acalculous cholecystitis and can result in gallbladder perforation [<a href="#rid23">23</a>]. Emphysematous cholecystitis, in particular, puts patients at risk for perforation. Overall, perforation occurs in approximately 10 percent of patients with acalculous cholecystitis [<a href="#rid14">14</a>]. Perforation may result in a cholecystenteric fistula, abscess formation, or free perforation with generalized peritonitis. In patients with gangrene without perforation, complications include acute pancreatitis, colonic perforation, and obstruction of the common hepatic duct. These complications are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis", section on 'History'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">DIAGNOSTIC APPROACH</span></p><p class="headingAnchor" id="H68737917"><span class="h2">Clinical suspicion and evaluation</span><span class="headingEndMark"> — </span>Acalculous cholecystitis should be suspected in critically ill patients with sepsis without a clear source or jaundice. It should also be considered in patients with postoperative jaundice. (See  <a class="medical medical_review" href="/d/html/3615.html" rel="external">"Classification and causes of jaundice or asymptomatic hyperbilirubinemia", section on 'Disorders associated with conjugated hyperbilirubinemia'</a> and  <a class="medical medical_review" href="/d/html/3604.html" rel="external">"Approach to the patient with postoperative jaundice", section on 'Acalculous cholecystitis'</a>.)</p><p>We perform abdominal imaging with an ultrasonography in patients with suspected acalculous cholecystitis [<a href="#rid9">9,19,24,25</a>]. In patients in whom the diagnosis is uncertain, we perform abdominal imaging with a contrast-enhanced abdominal computed tomography (CT) scan for evidence of acute acalculous cholecystitis and to exclude other causes of acute abdominal pain. In stable patients in whom the diagnosis is unclear after ultrasonography and abdominal CT scan, we perform a hepatic iminodiacetic acid (HIDA) scan [<a href="#rid26">26</a>]. (See <a class="local">'Imaging'</a> below.)</p><p>Laboratory evaluation should include a complete blood count, electrolytes, liver tests, pancreatic enzymes. In addition, we perform a urine analysis to look for evidence of urosepsis, and a chest radiograph or CT scan to rule out pneumonia. Blood cultures should be obtained in all patients with suspected acalculous cholecystitis. Culture results can guide narrowing of empiric antibiotics. (See <a class="local">'Antibiotics'</a> below and  <a class="medical medical_review" href="/d/html/101694.html" rel="external">"Antimicrobial approach to intra-abdominal infections in adults", section on 'Assessment of culture data'</a>.)</p><p class="headingAnchor" id="H1925297594"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>Imaging in acalculous cholecystitis is not specific enough to make the diagnosis alone. Imaging findings must be interpreted in the context of the clinical presentation. (See <a class="local">'Diagnosis'</a> below.)</p><p class="headingAnchor" id="H68737932"><span class="h3">Ultrasonography</span><span class="headingEndMark"> — </span>Ultrasonography is noninvasive and can be performed at the bedside in critically ill patients. Radiologic features suggestive of acalculous cholecystitis include: </p><p class="bulletIndent1"><span class="glyph">●</span>3.5- to 4-mm (or more) thick wall (if the gallbladder is distended to at least 5-cm longitudinally, and the patient has no ascites or hypoalbuminemia) </p><p class="bulletIndent1"><span class="glyph">●</span>Sonographic Murphy's sign is defined as inspiratory arrest during deep breath while gallbladder is being insonated) </p><p class="bulletIndent1"><span class="glyph">●</span>Pericholecystic fluid (halo)/subserosal edema</p><p></p><p>Other imaging findings in patients with acalculous cholecystitis include:</p><p class="bulletIndent1"><span class="glyph">●</span>Intramural gas</p><p class="bulletIndent1"><span class="glyph">●</span>Sloughed mucosal membrane</p><p class="bulletIndent1"><span class="glyph">●</span>Echogenic bile (sludge)</p><p class="bulletIndent1"><span class="glyph">●</span>Hydrops (distension greater than 8-cm longitudinally or 5-cm transversely, with clear fluid)</p><p></p><p>The reported sensitivity of ultrasound for acalculous cholecystitis ranges from 30 to 92 percent [<a href="#rid23">23,27</a>]. However, these data are derived from small, mostly retrospective studies with use of different criteria for sonographic diagnosis. </p><p>The specificity of ultrasound for acalculous cholecystitis ranges from 89 to 100 percent [<a href="#rid23">23,27</a>]. Sonographic Murphy's sign is operator-dependent and requires an awake and cooperative patient, but, when present, is indicative of gallbladder inflammation. Thickening of the gallbladder wall is the most reliable feature seen in patients with acalculous cholecystitis but is not specific [<a href="#rid23">23</a>]. False positive results may be due to hypoalbuminemia, ascites, sludge, non-shadowing stones, or cholesterolosis which can mimic a thickened gallbladder wall. </p><p>Gallbladder abnormalities are detected in a significant number of critically ill patients even in the absence of acalculous cholecystitis. In one study of 44 critically ill patients, at least one sonographic abnormality was detected in 37 patients (84 percent) and up to three sonographic abnormalities were detected in 25 (57 percent). However, only two had acalculous cholecystitis [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H573015687"><span class="h3">Computed tomography</span><span class="headingEndMark"> — </span>The accuracy of CT scan appears to be similar to that seen with ultrasonography [<a href="#rid29">29,30</a>]. CT scan findings suggestive of acalculous cholecystitis include [<a href="#rid23">23</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Gallbladder wall thickening (&gt;3 mm)</p><p class="bulletIndent1"><span class="glyph">●</span>Subserosal edema</p><p class="bulletIndent1"><span class="glyph">●</span>Pericholecystic fluid</p><p class="bulletIndent1"><span class="glyph">●</span>Mucosal sloughing</p><p class="bulletIndent1"><span class="glyph">●</span>Intramural gas</p><p class="bulletIndent1"><span class="glyph">●</span>Hyperdense bile (sludge)</p><p class="bulletIndent1"><span class="glyph">●</span>Gallbladder distention (&gt;5 cm)</p><p></p><p>Gallbladder abnormalities are highly prevalent in critically ill patients and in one retrospective study of CT scan images of 127 critically ill patients, abnormal findings in the gallbladder were present in 96 percent. Of these findings, gas in the gallbladder wall or lumen, lack of gallbladder wall enhancement, and edema around the gallbladder have the highest specificity for acalculous cholecystitis (99, 95, and 92 percent, respectively), but these findings have poor sensitivity (11, 38, and 22 percent, respectively).</p><p class="headingAnchor" id="H68737952"><span class="h3">Cholescintigraphy</span><span class="headingEndMark"> — </span>Technetium labeled HIDA is injected intravenously and is then taken up selectively by hepatocytes and excreted into bile. If the cystic duct is patent, the tracer will enter the gallbladder, leading to its visualization without the need for concentration. Normally, visualization of contrast within the common bile duct, gallbladder, and small bowel occurs within 30 to 60 minutes. Failure to opacify the gallbladder at one hour is considered a positive test. Leakage into the pericholecystic space suggests gallbladder perforation. </p><p>As cholescintigraphy (HIDA scan) takes hours to perform, it is not recommended in critically ill patients in whom a delay in therapy can be potentially fatal. The sensitivity of cholescintigraphy for acalculous cholecystitis ranges from 67 to 100 percent [<a href="#rid31">31</a>]. False negatives are rare but can occur in the following conditions [<a href="#rid32">32</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Cystic duct patency despite a diseased gallbladder</p><p class="bulletIndent1"><span class="glyph">●</span>Bowel loop simulation of the gallbladder</p><p class="bulletIndent1"><span class="glyph">●</span>Bile leak from gallbladder perforation</p><p class="bulletIndent1"><span class="glyph">●</span>Tracer activity in the kidneys simulating the small bowel or the gallbladder</p><p></p><p>The specificity of cholescintigraphy for acalculous cholecystitis ranges from 58 to 88 percent [<a href="#rid31">31</a>]. The accuracy can be improved by injection of intravenous <a class="drug drug_general" data-topicid="9788" href="/d/drug information/9788.html" rel="external">morphine</a> in patients with nonvisualization of the gallbladder to increase bile secretory pressure, which promotes gallbladder filling in the absence of acalculous cholecystitis. If the gallbladder is not visualized in 30 minutes after morphine injection, it is considered a positive study. However, several conditions that can lead to false-positive results include: </p><p class="bulletIndent1"><span class="glyph">●</span>Severe hepatocellular disease can lead to abnormal uptake and excretion of the tracer.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fasting and administration of total <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> can result in false positive results because the gallbladder is full due to prolonged lack of stimulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Biliary sphincterotomy can result in low resistance for bile flow, leading to preferential excretion of the tracer into the duodenum without filling of the gallbladder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe illness is associated with poor emptying of the gallbladder due to the stress of systemic inflammation and ischemia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rapid biliary to bowel transit.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prior cholecystectomy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hyperbilirubinemia, which may be associated with impaired hepatic clearance of iminodiacetic acid compounds. Other agents (diisopropyl and m-bromothymethyl iminodiacetic acid) used in cholescintigraphy have generally overcome this limitation.</p><p></p><p class="headingAnchor" id="H1798415141"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of acalculous cholecystitis is based upon a constellation of symptoms and signs (eg, critically ill patients with sepsis without a clear source or jaundice) in the setting of supportive imaging findings, and the exclusion of alternative diagnoses. Imaging in acalculous cholecystitis is not specific enough to make the diagnosis alone and must be interpreted in the context of the clinical presentation. </p><p>The diagnosis of acalculous cholecystitis is often made in patients with all of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever, abdominal pain, leukocytosis and/or elevated liver tests (see <a class="local">'Clinical manifestations'</a> above)</p><p class="bulletIndent1"><span class="glyph">●</span>Risk factors for acalculous cholecystitis  (<a class="graphic graphic_table graphicRef82539" href="/d/graphic/82539.html" rel="external">table 1</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Radiologic features suggestive of acalculous cholecystitis (eg, gallbladder wall thickening, sonographic Murphy’s sign, pericholecystic fluid) (see <a class="local">'Imaging'</a> above)</p><p class="bulletIndent1"><span class="glyph">●</span>No evidence of other conditions that could elicit the clinical and radiographic findings</p><p></p><p class="headingAnchor" id="H4"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of acalculous cholecystitis includes other causes of sepsis (eg, pneumonia, urinary tract infection), right upper quadrant pain and/or jaundice. These include: </p><p class="bulletIndent1"><span class="glyph">●</span>Acute calculous cholecystitis</p><p class="bulletIndent1"><span class="glyph">●</span>Acute pancreatitis</p><p class="bulletIndent1"><span class="glyph">●</span>Hepatic or subphrenic abscess</p><p class="bulletIndent1"><span class="glyph">●</span>Right-sided pyelonephritis</p><p></p><p>These conditions can be ruled out by clinical examination, laboratory tests, and imaging (eg, abdominal computed tomographic scan) performed as part of the evaluation in patients with suspected acalculous cholecystitis. (See <a class="local">'Clinical suspicion and evaluation'</a> above and <a class="local">'Diagnostic approach'</a> above and  <a class="medical medical_review" href="/d/html/5652.html" rel="external">"Clinical manifestations and diagnosis of acute pancreatitis"</a> and  <a class="medical medical_review" href="/d/html/2680.html" rel="external">"Pyogenic liver abscess"</a> and  <a class="medical medical_review" href="/d/html/16109.html" rel="external">"Acute complicated urinary tract infection (including pyelonephritis) in adults and adolescents"</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Prompt treatment of acalculous cholecystitis is imperative because without it, gallbladder gangrene may develop and can result in gallbladder perforation [<a href="#rid19">19,23</a>]. If treatment is delayed, mortality rates from acalculous cholecystitis may be as high as 75 percent [<a href="#rid33">33,34</a>]. With treatment, the mortality rate in acalculous cholecystitis is approximately 30 percent. </p><p class="headingAnchor" id="H3708506612"><span class="h2">Overall approach</span><span class="headingEndMark"> — </span>Patients diagnosed with acalculous cholecystitis require inpatient management, and based on their hemodynamic status, may need monitored or intensive care unit support. The management of acalculous cholecystitis includes supportive care with intravenous fluids, pain control, initiation of antibiotics (after blood cultures have been obtained), and definitive therapy with either cholecystectomy or gallbladder drainage  (<a class="graphic graphic_algorithm graphicRef115929" href="/d/graphic/115929.html" rel="external">algorithm 1</a>). Antibiotic therapy augments but does not replace definitive therapy because purulent material in the gallbladder needs to be removed or drained. </p><p>The initial choice between cholecystectomy or a gallbladder drainage procedure depends on the patient’s overall status, disease stage, and available local expertise:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with one of the indications for an emergency cholecystectomy can only be treated with cholecystectomy. Indications for an emergency cholecystectomy include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Gallbladder necrosis</p><p class="bulletIndent2"><span class="glyph">•</span>Emphysematous cholecystitis</p><p class="bulletIndent2"><span class="glyph">•</span>Gallbladder perforation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients without indications for emergency cholecystectomy, who are critically ill or in poor health, or unfit for general anesthesia should be treated with gallbladder drainage. (See <a class="local">'Gallbladder drainage'</a> below.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients without indications for emergency cholecystectomy who are of low surgical and anesthetic risk (eg, ASA class I or II) can be treated with either cholecystectomy or gallbladder drainage. The decision should be made based on available local resources (surgeon, interventional radiologist, and endoscopist) and patient preference. Existing literature on this subject consists of either single-institution retrospective series [<a href="#rid35">35,36</a>], or large administrative database reviews [<a href="#rid37">37,38</a>], neither of which can be relied upon to make a definitive recommendation [<a href="#rid39">39</a>]. </p><p></p><p>Patients typically respond to a gallbladder drainage procedure within 24 hours. Failure to improve (defined as persistent fever, signs of sepsis, or evidence of new multiorgan dysfunction) may be due to gangrenous cholecystitis, catheter dislodgement, bile leakage resulting in peritonitis, or an incorrect diagnosis of acalculous cholecystitis. In such patients, rescue cholecystectomy is required, or mortality is imminent. </p><p>Patients who are successfully treated with a gallbladder drainage procedure in combination with antibiotics may have the cholecystostomy tube removed when acalculous cholecystitis resolves and drainage is minimal  (<a class="graphic graphic_algorithm graphicRef115929" href="/d/graphic/115929.html" rel="external">algorithm 1</a>). Because the recurrence rate is low after true acute acalculous cholecystitis, and patients are generally high-risk, interval cholecystectomy is typically not required [<a href="#rid40">40</a>]. However, patients should undergo repeat abdominal ultrasound to exclude the presence of gallstones and sludge, the presence of which is an indication for surgery in suitable candidates. In patients undergoing cholecystectomy, the cholecystostomy tube is removed at the time of surgery. (See <a class="local">'Management following gallbladder drainage'</a> below.)</p><p class="headingAnchor" id="H1831250012"><span class="h2">General measures for all patients</span></p><p class="headingAnchor" id="H3292080450"><span class="h3">Supportive care</span><span class="headingEndMark"> — </span>Supportive care includes intravenous hydration and correction of any associated electrolyte disorders, pain control, and treatment of the underlying predisposing cause. </p><p>Patients should be kept fasting, and although uncommonly needed, those who are vomiting should have placement of a nasogastric tube. Pain control in patients can usually be achieved with nonsteroidal anti-inflammatory drugs or opioids. Progression of pain during treatment for acute cholecystitis, despite adequate analgesia, is an indicator of a clinical progression. </p><p class="headingAnchor" id="H68738107"><span class="h3">Antibiotics</span><span class="headingEndMark"> — </span>After blood cultures are obtained, intravenous broad spectrum antibiotics should be started. Acute cholecystitis is primarily an inflammatory process, but secondary infection of the gallbladder can occur as a result of cystic duct obstruction and bile stasis. </p><p>The choice of antibiotics should take into consideration whether the infection is community-acquired versus healthcare-associated, individual risk factors for infection with resistant bacteria and risk for adverse outcomes  (<a class="graphic graphic_table graphicRef105865" href="/d/graphic/105865.html" rel="external">table 3</a>). We recommend the following antibiotic regimens for patients with acute cholecystitis based on their individual risk category [<a href="#rid41">41</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>For patients with community-acquired acute cholecystitis of low risk  (<a class="graphic graphic_table graphicRef106948" href="/d/graphic/106948.html" rel="external">table 4</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with community-acquired acute cholecystitis of high risk  (<a class="graphic graphic_table graphicRef106949" href="/d/graphic/106949.html" rel="external">table 5</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with healthcare-associated acute cholecystitis  (<a class="graphic graphic_table graphicRef106950" href="/d/graphic/106950.html" rel="external">table 6</a>). </p><p></p><p>However, given that <strong>acalculous</strong> cholecystitis almost exclusively occurs in hospitalized patients who are acutely ill [<a href="#rid42">42-44</a>], most will have healthcare-associate acute cholecystitis. </p><p>The chosen antimicrobial agents should subsequently be tailored to culture and susceptibility results when they become available. The duration of antibiotics depends on the adequacy of control of infection and the clinically stability of the patient. Antibiotic therapy for intra-abdominal infections, including acute cholecystitis and the duration of therapy, are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/101694.html" rel="external">"Antimicrobial approach to intra-abdominal infections in adults", section on 'Empiric antimicrobial therapy'</a>.)</p><p class="headingAnchor" id="H2565053243"><span class="h2">Gallbladder drainage</span><span class="headingEndMark"> — </span>Although cholecystectomy was traditionally the preferred definitive treatment for acalculous cholecystitis, gallbladder drainage has been established as a safe, effective, and definitive alternative to surgery.</p><p class="headingAnchor" id="H68738121"><span class="h3">Percutaneous cholecystostomy</span><span class="headingEndMark"> — </span>Drainage of the gallbladder can be performed under radiologic guidance via a percutaneous cholecystostomy tube. Decompressing the gallbladder with a cholecystostomy allows both local inflammation and systemic illness to resolve [<a href="#rid35">35,45-56</a>]. Typically, a cholecystostomy tube is left in place until the acalculous cholecystitis has resolved. Patients with acalculous cholecystitis treated with cholecystostomy should improve rapidly (within 24 hours). (See <a class="local">'Overall approach'</a> above.)</p><p>The success rates for cholecystostomy range from 56 to 100 percent [<a href="#rid35">35,45-56</a>]. Complications include hemorrhage, sepsis, bile peritonitis, pneumothorax, intestinal perforation, secondary infection of the gallbladder, and catheter dislodgement [<a href="#rid23">23,51,52,57,58</a>].</p><p class="headingAnchor" id="H3460902059"><span class="h3">Endoscopic drainage</span><span class="headingEndMark"> — </span>Endoscopic gallbladder drainage is reserved for patients with acalculous cholecystitis in whom percutaneous approaches are contraindicated, or are not anatomically feasible (ie, advanced liver disease, ascites, or coagulopathy). Isolated cases of successful transpapillary endoscopic drainage of the gallbladder have been reported. Transpapillary drainage utilizes endoscopic retrograde cholangiography techniques and equipment to place a drainage catheter into the gallbladder via the cystic duct. The other end of the catheter is either brought out through the nose (nasobiliary drain) or left to drain internally into the duodenum.</p><p>An approach utilizing endoscopic ultrasound has been shown to be effective and similar to percutaneous drainage. This technique involves a trans-gastric approach from the antrum or proximal duodenum with endoscopic ultrasound guidance and can be used to place a metallic lumen-apposing stent that drains the gallbladder internally without need for an external drainage system [<a href="#rid59">59</a>]. </p><p class="headingAnchor" id="H1036773166"><span class="h3">Management following gallbladder drainage</span><span class="headingEndMark"> — </span>Once the episode of acalculous cholecystitis has resolved, cholecystectomy is typically not required [<a href="#rid47">47,48</a>]. The risk of recurrent cholecystitis appears to be low among those treated with cholecystostomy drainage. In a retrospective study that included 57 patients with acalculous cholecystitis, of the 28 patients who were managed with percutaneous cholecystostomy, 2 (7 percent) had recurrent acalculous cholecystitis over a median 32 month follow-up [<a href="#rid35">35</a>]. </p><p>Patients should undergo an abdominal ultrasound to evaluate for gallstones that may have been missed on prior imaging  (<a class="graphic graphic_algorithm graphicRef115929" href="/d/graphic/115929.html" rel="external">algorithm 1</a>). </p><p class="bulletIndent1"><span class="glyph">●</span>If gallstones or sludge are found, elective cholecystectomy should be performed in surgical candidates. The cholecystostomy tube should be left in place until the cholecystectomy. (See  <a class="medical medical_review" href="/d/html/15096.html" rel="external">"Open cholecystectomy"</a> and  <a class="medical medical_review" href="/d/html/3685.html" rel="external">"Laparoscopic cholecystectomy"</a> and  <a class="medical medical_review" href="/d/html/3681.html" rel="external">"Complications of laparoscopic cholecystectomy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients without gallstones or sludge, the cholecystostomy tube can be removed when there is minimal drainage (less than 10 cc per day). This is typically four to six weeks after cholecystostomy tube placement. </p><p></p><p class="headingAnchor" id="H3022424028"><span class="h2">Cholecystectomy</span><span class="headingEndMark"> — </span>Both open and laparoscopic approaches have been used for the surgical treatment of acalculous cholecystitis [<a href="#rid3">3,19,60</a>]. The gallbladder is often encased in an inflammatory mass, which makes laparoscopic cholecystectomy more complicated because of a higher risk of bile duct and vascular injuries. However, a laparoscopic approach is still preferred in critically ill patients. It is appropriate for the experienced surgeon to attempt a laparoscopic approach but convert to an open cholecystectomy if necessary. (See  <a class="medical medical_review" href="/d/html/15096.html" rel="external">"Open cholecystectomy"</a> and  <a class="medical medical_review" href="/d/html/3685.html" rel="external">"Laparoscopic cholecystectomy"</a> and  <a class="medical medical_review" href="/d/html/3681.html" rel="external">"Complications of laparoscopic cholecystectomy"</a>.)</p><p>Timely cholecystectomy has been associated with survival rates of greater than 90 percent in patients with acute cholecystitis related to trauma, although lower survival rates would be expected in patients who develop acalculous cholecystitis in the setting of a critical illness [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H7"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Acalculous cholecystitis is associated with a high mortality rate. Mortality in patients with acalculous cholecystitis depends upon coexistent medical or surgical conditions and the rapidity of diagnosis. Gallbladder necrosis, gangrene, and perforation are frequently present at the time of diagnosis, particularly in the critically ill, and are associated with poor outcomes [<a href="#rid1">1,19</a>]. The mortality rate can be as high as 90 percent in critically ill patients or as low as 10 percent in community-acquired cases [<a href="#rid19">19,61</a>]. Overall, the mortality rate is approximately 30 percent, which in part reflects the fact that acalculous cholecystitis typically develops in patients who are already critically ill [<a href="#rid23">23</a>]. If treatment is delayed, mortality rates may be as high as 75 percent [<a href="#rid33">33,34</a>]. The cause of death in most patients with acalculous cholecystitis is sepsis with multiorgan failure [<a href="#rid62">62</a>]. </p><p class="headingAnchor" id="H59382193"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115384.html" rel="external">"Society guideline links: Cholecystitis and other gallbladder disorders"</a>.)</p><p class="headingAnchor" id="H8"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology –</strong> Acalculous cholecystitis is an acute necroinflammatory disease of the gallbladder with a multifactorial pathogenesis. It accounts for approximately 10 percent of all cases of acute cholecystitis and is associated with high morbidity and mortality rates. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> <strong>–</strong> Acalculous cholecystitis is typically seen in patients who are hospitalized and critically ill, although it may also be seen in the outpatient setting  (<a class="graphic graphic_table graphicRef82539" href="/d/graphic/82539.html" rel="external">table 1</a>). In critically ill patients, the appearance of unexplained fever, leukocytosis, or vague abdominal discomfort may be the only sign of acalculous cholecystitis. Because the presentation may be insidious, gallbladder necrosis, gangrene, and perforation are frequently present at the time of diagnosis. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>When to suspect and choice of imaging</strong> <strong>–</strong> Acalculous cholecystitis should be suspected in critically ill patients with sepsis without a clear source or jaundice. It should also be considered in patients with postoperative jaundice. We perform abdominal imaging with ultrasonography in patients with suspected acalculous cholecystitis. In patients in whom the diagnosis is uncertain, we perform a contrast-enhanced abdominal computed tomography (CT) scan for evidence of acute acalculous cholecystitis and to exclude other causes of acute abdominal pain. In stable patients in whom the diagnosis is unclear after ultrasonography and abdominal CT scan, we perform a hepatic iminodiacetic acid scan. (See <a class="local">'Clinical suspicion and evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> <strong>–</strong> Imaging in acute acalculous cholecystitis is not specific enough to make the diagnosis alone. The diagnosis of acute acalculous cholecystitis is based upon a constellation of symptoms and signs in the setting of supportive imaging findings, and the exclusion of alternative diagnoses. The diagnosis of acute acalculous cholecystitis is often made in patients with all of the following (see <a class="local">'Diagnosis'</a> above and <a class="local">'Imaging'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fever, abdominal pain, leukocytosis and/or elevated liver tests</p><p class="bulletIndent2"><span class="glyph">•</span>Risk factors for acute acalculous cholecystitis  (<a class="graphic graphic_table graphicRef82539" href="/d/graphic/82539.html" rel="external">table 1</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Radiologic features suggestive of acalculous cholecystitis</p><p class="bulletIndent2"><span class="glyph">•</span>No evidence of other condition that could elicit the clinical and radiographic findings</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>General measures</strong> <strong>–</strong> Patients with acalculous cholecystitis require supportive care with intravenous fluids, correction of electrolyte abnormalities, bowel rest, and pain control  (<a class="graphic graphic_algorithm graphicRef115929" href="/d/graphic/115929.html" rel="external">algorithm 1</a>). In patients with acalculous cholecystitis, we recommend the initiation of broad spectrum antibiotics as soon as blood cultures have been drawn, rather than waiting for blood culture results (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). The choice of antibiotics should take into consideration whether the infection is community-acquired versus healthcare-associated, individual risk factors for infection with resistant bacteria, and risk for adverse outcomes  (<a class="graphic graphic_table graphicRef105865" href="/d/graphic/105865.html" rel="external">table 3</a>). (See <a class="local">'Antibiotics'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Definitive treatment with drainage or cholecystectomy</strong> <strong>–</strong> We recommend definitive treatment with either cholecystectomy or cholecystostomy for patients with acalculous cholecystitis, rather than continued supportive care (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). The initial choice between cholecystectomy or a gallbladder drainage procedure depends on the patient's overall status (indications for emergency cholecystectomy), disease stage, and available local expertise. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patients with the indications for an emergency cholecystectomy</strong> <strong>–</strong> Indications for an emergency cholecystectomy include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Gallbladder necrosis</p><p class="bulletIndent3"><span class="glyph">-</span>Emphysematous cholecystitis</p><p class="bulletIndent3"><span class="glyph">-</span>Gallbladder perforation</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patients without indications for emergency cholecystectomy</strong> <strong>– </strong>In patients with acalculous cholecystitis who do not have indications for emergency cholecystectomy, we suggest cholecystostomy rather than cholecystectomy  (<a class="graphic graphic_algorithm graphicRef115929" href="/d/graphic/115929.html" rel="external">algorithm 1</a>) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Cholecystostomy is effective and is less invasive than cholecystectomy. However, cholecystectomy is also a reasonable alternative in patients who are good surgical candidates. </p><p></p><p class="bulletIndent2">Patients with acalculous cholecystitis who fail to improve within 24 to 48 hours following cholecystostomy require emergency cholecystectomy  (<a class="graphic graphic_algorithm graphicRef115929" href="/d/graphic/115929.html" rel="external">algorithm 1</a>). (See <a class="local">'Overall approach'</a> above and <a class="local">'Gallbladder drainage'</a> above and <a class="local">'Cholecystectomy'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> <strong>–</strong> Acalculous cholecystitis is associated with a high mortality rate. Mortality in patients with acalculous cholecystitis depends upon coexistent medical or surgical conditions and the rapidity of diagnosis. The risk of recurrent cholecystitis appears to be low among those treated with cholecystostomy drainage. Once the episode of acalculous cholecystitis has resolved, cholecystectomy is typically not required in the absence of concurrent gallstones or sludge. (See <a class="local">'Management following gallbladder drainage'</a> above and <a class="local">'Prognosis'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Shapiro MJ, Luchtefeld WB, Kurzweil S, et al. Acute acalculous cholecystitis in the critically ill. Am Surg 1994; 60:335.</a></li><li><a class="nounderline abstract_t">Gofrit O, Eid A, Pikarsky A, et al. Cholesterol embolisation causing chronic acalculous cholecystitis. Eur J Surg 1996; 162:243.</a></li><li><a class="nounderline abstract_t">Schwesinger WH, Diehl AK. Changing indications for laparoscopic cholecystectomy. Stones without symptoms and symptoms without stones. Surg Clin North Am 1996; 76:493.</a></li><li><a class="nounderline abstract_t">Wiboltt KS, Jeffrey RB Jr. Acalculous cholecystitis in patients undergoing bone marrow transplantation. Eur J Surg 1997; 163:519.</a></li><li><a class="nounderline abstract_t">Romero Ganuza FJ, La Banda G, Montalvo R, Mazaira J. Acute acalculous cholecystitis in patients with acute traumatic spinal cord injury. Spinal Cord 1997; 35:124.</a></li><li><a class="nounderline abstract_t">Nash JA, Cohen SA. Gallbladder and biliary tract disease in AIDS. Gastroenterol Clin North Am 1997; 26:323.</a></li><li><a class="nounderline abstract_t">McChesney JA, Northup PG, Bickston SJ. Acute acalculous cholecystitis associated with systemic sepsis and visceral arterial hypoperfusion: a case series and review of pathophysiology. Dig Dis Sci 2003; 48:1960.</a></li><li><a class="nounderline abstract_t">Wind P, Chevallier JM, Jones D, et al. Cholecystectomy for cholecystitis in patients with acquired immune deficiency syndrome. Am J Surg 1994; 168:244.</a></li><li><a class="nounderline abstract_t">Wang AJ, Wang TE, Lin CC, et al. Clinical predictors of severe gallbladder complications in acute acalculous cholecystitis. World J Gastroenterol 2003; 9:2821.</a></li><li><a class="nounderline abstract_t">Venkataramani A, Strong RM, Anderson DS, et al. Abnormal duodenal bile composition in patients with acalculous chronic cholecystitis. Am J Gastroenterol 1998; 93:434.</a></li><li><a class="nounderline abstract_t">Janowitz P, Kratzer W, Zemmler T, et al. Gallbladder sludge: spontaneous course and incidence of complications in patients without stones. Hepatology 1994; 20:291.</a></li><li class="breakAll">Barie PS. Acalculous and postoperative cholecystitis. In: Surgical intensive care, Barie PS, Shires GT (Eds), Little Brown &amp; Co, Boston 1993. p.837.</li><li><a class="nounderline abstract_t">Ouriel K, Green RM, Ricotta JJ, et al. Acute acalculous cholecystitis complicating abdominal aortic aneurysm resection. J Vasc Surg 1984; 1:646.</a></li><li><a class="nounderline abstract_t">Hagino RT, Valentine RJ, Clagett GP. Acalculous cholecystitis after aortic reconstruction. J Am Coll Surg 1997; 184:245.</a></li><li><a class="nounderline abstract_t">Cadot H, Addis MD, Faries PL, et al. Abdominal aortic aneurysmorrhaphy and cholelithiasis in the era of endovascular surgery. Am Surg 2002; 68:839.</a></li><li><a class="nounderline abstract_t">Ganpathi IS, Diddapur RK, Eugene H, Karim M. Acute acalculous cholecystitis: challenging the myths. HPB (Oxford) 2007; 9:131.</a></li><li><a class="nounderline abstract_t">Savoca PE, Longo WE, Zucker KA, et al. The increasing prevalence of acalculous cholecystitis in outpatients. Results of a 7-year study. Ann Surg 1990; 211:433.</a></li><li><a class="nounderline abstract_t">Ryu JK, Ryu KH, Kim KH. Clinical features of acute acalculous cholecystitis. J Clin Gastroenterol 2003; 36:166.</a></li><li><a class="nounderline abstract_t">Kalliafas S, Ziegler DW, Flancbaum L, Choban PS. Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg 1998; 64:471.</a></li><li><a class="nounderline abstract_t">Adams DB, Tarnasky PR, Hawes RH, et al. Outcome after laparoscopic cholecystectomy for chronic acalculous cholecystitis. Am Surg 1998; 64:1.</a></li><li><a class="nounderline abstract_t">Jagannath SB, Singh VK, Cruz-Correa M, et al. A long-term cohort study of outcome after cholecystectomy for chronic acalculous cholecystitis. Am J Surg 2003; 185:91.</a></li><li><a class="nounderline abstract_t">Trowbridge RL, Rutkowski NK, Shojania KG. Does this patient have acute cholecystitis? JAMA 2003; 289:80.</a></li><li><a class="nounderline abstract_t">Barie PS, Eachempati SR. Acute acalculous cholecystitis. Gastroenterol Clin North Am 2010; 39:343.</a></li><li><a class="nounderline abstract_t">Laméris JS, van Overhagen H. Imaging and intervention in patients with acute right upper quadrant disease. Baillieres Clin Gastroenterol 1995; 9:21.</a></li><li><a class="nounderline abstract_t">Molenat F, Boussuges A, Valantin V, Sainty JM. Gallbladder abnormalities in medical ICU patients: an ultrasonographic study. Intensive Care Med 1996; 22:356.</a></li><li><a class="nounderline abstract_t">Westlake PJ, Hershfield NB, Kelly JK, et al. Chronic right upper quadrant pain without gallstones: does HIDA scan predict outcome after cholecystectomy? Am J Gastroenterol 1990; 85:986.</a></li><li><a class="nounderline abstract_t">Huffman JL, Schenker S. Acute acalculous cholecystitis: a review. Clin Gastroenterol Hepatol 2010; 8:15.</a></li><li><a class="nounderline abstract_t">Boland GW, Slater G, Lu DS, et al. Prevalence and significance of gallbladder abnormalities seen on sonography in intensive care unit patients. AJR Am J Roentgenol 2000; 174:973.</a></li><li><a class="nounderline abstract_t">Mirvis SE, Whitley NO, Miller JW. CT diagnosis of acalculous cholecystitis. J Comput Assist Tomogr 1987; 11:83.</a></li><li><a class="nounderline abstract_t">Mirvis SE, Vainright JR, Nelson AW, et al. The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT. AJR Am J Roentgenol 1986; 147:1171.</a></li><li><a class="nounderline abstract_t">Mariat G, Mahul P, Prév t N, et al. Contribution of ultrasonography and cholescintigraphy to the diagnosis of acute acalculous cholecystitis in intensive care unit patients. Intensive Care Med 2000; 26:1658.</a></li><li><a class="nounderline abstract_t">Appropriate Use Criteria for Hepatobiliary Scintigraphy in Abdominal Pain: Summary and Excerpts. J Nucl Med 2017; 58:9N.</a></li><li><a class="nounderline abstract_t">Cornwell EE 3rd, Rodriguez A, Mirvis SE, Shorr RM. Acute acalculous cholecystitis in critically injured patients. Preoperative diagnostic imaging. Ann Surg 1989; 210:52.</a></li><li><a class="nounderline abstract_t">DuPriest RW Jr, Khaneja SC, Cowley RA. Acute cholecystitis complicating trauma. Ann Surg 1979; 189:84.</a></li><li><a class="nounderline abstract_t">Chung YH, Choi ER, Kim KM, et al. Can percutaneous cholecystostomy be a definitive management for acute acalculous cholecystitis? J Clin Gastroenterol 2012; 46:216.</a></li><li><a class="nounderline abstract_t">Simorov A, Ranade A, Parcells J, et al. Emergent cholecystostomy is superior to open cholecystectomy in extremely ill patients with acalculous cholecystitis: a large multicenter outcome study. Am J Surg 2013; 206:935.</a></li><li><a class="nounderline abstract_t">Anderson JE, Inui T, Talamini MA, Chang DC. Cholecystostomy offers no survival benefit in patients with acute acalculous cholecystitis and severe sepsis and shock. J Surg Res 2014; 190:517.</a></li><li><a class="nounderline abstract_t">Anderson JE, Chang DC, Talamini MA. A nationwide examination of outcomes of percutaneous cholecystostomy compared with cholecystectomy for acute cholecystitis, 1998-2010. Surg Endosc 2013; 27:3406.</a></li><li><a class="nounderline abstract_t">Soria Aledo V, Galindo Iñíguez L, Flores Funes D, et al. Is cholecystectomy the treatment of choice for acute acalculous cholecystitis? A systematic review of the literature. Rev Esp Enferm Dig 2017; 109:708.</a></li><li><a class="nounderline abstract_t">Abbas SH, Ghazanfar MA, Gordon-Weeks AN, et al. Acalculous Cholecystitis: Is an Elective Interval Cholecystectomy Necessary. Dig Surg 2018; 35:171.</a></li><li><a class="nounderline abstract_t">Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:133.</a></li><li><a class="nounderline abstract_t">Thampy R, Khan A, Zaki IH, et al. Acute Acalculous Cholecystitis in Hospitalized Patients With Hematologic Malignancies and Prognostic Importance of Gallbladder Ultrasound Findings. J Ultrasound Med 2019; 38:51.</a></li><li><a class="nounderline abstract_t">Laurila J, Syrjälä H, Laurila PA, et al. Acute acalculous cholecystitis in critically ill patients. Acta Anaesthesiol Scand 2004; 48:986.</a></li><li><a class="nounderline abstract_t">Walsh K, Goutos I, Dheansa B. Acute Acalculous Cholecystitis in Burns: A Review. J Burn Care Res 2018; 39:724.</a></li><li><a class="nounderline abstract_t">Yang HK, Hodgson WJ. Laparoscopic cholecystostomy for acute acalculous cholecystitis. Surg Endosc 1996; 10:673.</a></li><li><a class="nounderline abstract_t">Boland GW, Lee MJ, Leung J, Mueller PR. Percutaneous cholecystostomy in critically ill patients: early response and final outcome in 82 patients. AJR Am J Roentgenol 1994; 163:339.</a></li><li><a class="nounderline abstract_t">McLoughlin RF, Patterson EJ, Mathieson JR, et al. Radiologically guided percutaneous cholecystostomy for acute cholecystitis: long-term outcome in 50 patients. Can Assoc Radiol J 1994; 45:455.</a></li><li><a class="nounderline abstract_t">Sugiyama M, Tokuhara M, Atomi Y. Is percutaneous cholecystostomy the optimal treatment for acute cholecystitis in the very elderly? World J Surg 1998; 22:459.</a></li><li><a class="nounderline abstract_t">vanSonnenberg E, D'Agostino HB, Goodacre BW, et al. Percutaneous gallbladder puncture and cholecystostomy: results, complications, and caveats for safety. Radiology 1992; 183:167.</a></li><li><a class="nounderline abstract_t">England RE, McDermott VG, Smith TP, et al. Percutaneous cholecystostomy: who responds? AJR Am J Roentgenol 1997; 168:1247.</a></li><li><a class="nounderline abstract_t">Davis CA, Landercasper J, Gundersen LH, Lambert PJ. Effective use of percutaneous cholecystostomy in high-risk surgical patients: techniques, tube management, and results. Arch Surg 1999; 134:727.</a></li><li><a class="nounderline abstract_t">Akhan O, Akinci D, Ozmen MN. Percutaneous cholecystostomy. Eur J Radiol 2002; 43:229.</a></li><li><a class="nounderline abstract_t">Lee MJ, Saini S, Brink JA, et al. Treatment of critically ill patients with sepsis of unknown cause: value of percutaneous cholecystostomy. AJR Am J Roentgenol 1991; 156:1163.</a></li><li><a class="nounderline abstract_t">Lo LD, Vogelzang RL, Braun MA, Nemcek AA Jr. Percutaneous cholecystostomy for the diagnosis and treatment of acute calculous and acalculous cholecystitis. J Vasc Interv Radiol 1995; 6:629.</a></li><li><a class="nounderline abstract_t">Joseph T, Unver K, Hwang GL, et al. Percutaneous cholecystostomy for acute cholecystitis: ten-year experience. J Vasc Interv Radiol 2012; 23:83.</a></li><li><a class="nounderline abstract_t">Saeed SA, Masroor I. Percutaneous cholecystostomy (PC) in the management of acute cholecystitis in high risk patients. J Coll Physicians Surg Pak 2010; 20:612.</a></li><li><a class="nounderline abstract_t">Spira RM, Nissan A, Zamir O, et al. Percutaneous transhepatic cholecystostomy and delayed laparoscopic cholecystectomy in critically ill patients with acute calculus cholecystitis. Am J Surg 2002; 183:62.</a></li><li><a class="nounderline abstract_t">Hadas-Halpern I, Patlas M, Knizhnik M, et al. Percutaneous cholecystostomy in the management of acute cholecystitis. Isr Med Assoc J 2003; 5:170.</a></li><li><a class="nounderline abstract_t">James TW, Baron TH. EUS-guided gallbladder drainage: A review of current practices and procedures. Endosc Ultrasound 2019; 8:S28.</a></li><li><a class="nounderline abstract_t">Hamp T, Fridrich P, Mauritz W, et al. Cholecystitis after trauma. J Trauma 2009; 66:400.</a></li><li><a class="nounderline abstract_t">Barie PS, Eachempati SR. Acute acalculous cholecystitis. Curr Gastroenterol Rep 2003; 5:302.</a></li><li><a class="nounderline abstract_t">Barie PS, Hydo LJ, Pieracci FM, et al. Multiple organ dysfunction syndrome in critical surgical illness. Surg Infect (Larchmt) 2009; 10:369.</a></li></ol></div><div id="topicVersionRevision">Topic 672 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8161083" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acute acalculous cholecystitis in the critically ill.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8695742" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Cholesterol embolisation causing chronic acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8669009" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Changing indications for laparoscopic cholecystectomy. Stones without symptoms and symptoms without stones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9248986" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Acalculous cholecystitis in patients undergoing bone marrow transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9044522" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Acute acalculous cholecystitis in patients with acute traumatic spinal cord injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9187927" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Gallbladder and biliary tract disease in AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14627341" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Acute acalculous cholecystitis associated with systemic sepsis and visceral arterial hypoperfusion: a case series and review of pathophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8080061" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Cholecystectomy for cholecystitis in patients with acquired immune deficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14669342" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical predictors of severe gallbladder complications in acute acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9517653" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Abnormal duodenal bile composition in patients with acalculous chronic cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8045489" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Gallbladder sludge: spontaneous course and incidence of complications in patients without stones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8045489" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Gallbladder sludge: spontaneous course and incidence of complications in patients without stones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6502835" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Acute acalculous cholecystitis complicating abdominal aortic aneurysm resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9060919" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Acalculous cholecystitis after aortic reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12412707" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Abdominal aortic aneurysmorrhaphy and cholelithiasis in the era of endovascular surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18333128" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Acute acalculous cholecystitis: challenging the myths.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2322038" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The increasing prevalence of acalculous cholecystitis in outpatients. Results of a 7-year study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12544202" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical features of acute acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9585788" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9457029" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Outcome after laparoscopic cholecystectomy for chronic acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12559435" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A long-term cohort study of outcome after cholecystectomy for chronic acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12503981" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Does this patient have acute cholecystitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20478490" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Acute acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7772813" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Imaging and intervention in patients with acute right upper quadrant disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8708175" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Gallbladder abnormalities in medical ICU patients: an ultrasonographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2375327" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Chronic right upper quadrant pain without gallstones: does HIDA scan predict outcome after cholecystectomy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19747982" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acute acalculous cholecystitis: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10749232" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Prevalence and significance of gallbladder abnormalities seen on sonography in intensive care unit patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3805432" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : CT diagnosis of acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3535451" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11193273" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Contribution of ultrasonography and cholescintigraphy to the diagnosis of acute acalculous cholecystitis in intensive care unit patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28572300" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Appropriate Use Criteria for Hepatobiliary Scintigraphy in Abdominal Pain: Summary and Excerpts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2662924" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Acute acalculous cholecystitis in critically injured patients. Preoperative diagnostic imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/758868" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Acute cholecystitis complicating trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21814147" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Can percutaneous cholecystostomy be a definitive management for acute acalculous cholecystitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24112675" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Emergent cholecystostomy is superior to open cholecystectomy in extremely ill patients with acalculous cholecystitis: a large multicenter outcome study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24679697" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cholecystostomy offers no survival benefit in patients with acute acalculous cholecystitis and severe sepsis and shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23549767" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A nationwide examination of outcomes of percutaneous cholecystostomy compared with cholecystectomy for acute cholecystitis, 1998-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28776380" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Is cholecystectomy the treatment of choice for acute acalculous cholecystitis? A systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28704814" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Acalculous Cholecystitis: Is an Elective Interval Cholecystectomy Necessary.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20034345" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29708270" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Acute Acalculous Cholecystitis in Hospitalized Patients With Hematologic Malignancies and Prognostic Importance of Gallbladder Ultrasound Findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15315616" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Acute acalculous cholecystitis in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29931066" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Acute Acalculous Cholecystitis in Burns: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8662413" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Laparoscopic cholecystostomy for acute acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8037026" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Percutaneous cholecystostomy in critically ill patients: early response and final outcome in 82 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7982107" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Radiologically guided percutaneous cholecystostomy for acute cholecystitis: long-term outcome in 50 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9564288" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Is percutaneous cholecystostomy the optimal treatment for acute cholecystitis in the very elderly?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1549666" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Percutaneous gallbladder puncture and cholecystostomy: results, complications, and caveats for safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9129421" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Percutaneous cholecystostomy: who responds?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10401823" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Effective use of percutaneous cholecystostomy in high-risk surgical patients: techniques, tube management, and results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12204405" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Percutaneous cholecystostomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2028859" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Treatment of critically ill patients with sepsis of unknown cause: value of percutaneous cholecystostomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7579876" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Percutaneous cholecystostomy for the diagnosis and treatment of acute calculous and acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22133709" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Percutaneous cholecystostomy for acute cholecystitis: ten-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20810055" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Percutaneous cholecystostomy (PC) in the management of acute cholecystitis in high risk patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11869705" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Percutaneous transhepatic cholecystostomy and delayed laparoscopic cholecystectomy in critically ill patients with acute calculus cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12725134" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Percutaneous cholecystostomy in the management of acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31897376" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : EUS-guided gallbladder drainage: A review of current practices and procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19204513" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Cholecystitis after trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12864960" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Acute acalculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19943773" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Multiple organ dysfunction syndrome in critical surgical illness.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
